Dr. Salman Ahmed
Anticancer potential of furanocoumarins: mechanistic and therapeutic aspects
Journal title : International Journal of Molecular Sciences
Publisher : MDPI AG
Online ISSN : 1422-0067
Page Number : 5622
Journal volume : 21
Journal issue : 16
322 Views Reviews Article
Cancer is one of the most extreme medical conditions in both developing and developed countries around the world, causing millions of deaths each year. Chemotherapy and radiotherapy are critical treatment approaches, but both have numerous adverse health effects. Furthermore, the resistance of cancerous cells to anticancer medication leads to treatment failure. The rising burden of cancer overall requires novel, efficacious treatment modalities. Natural medications offer feasible alternative options against malignancy in contrast to western medicines. Furanocoumarins’ defensive and restorative impacts have been observed in leukemia, glioma, breast, lung, renal, liver, colon, cervical, ovarian, and prostate malignancies. Experimental findings have shown that furanocoumarins activate multiple signalling pathways, leading to apoptosis, autophagy, antioxidant, antimetastatic, and cell cycle arrest in malignant cells. Additionally, furanocoumarins have been shown to have chemopreventive and chemotherapeutic synergistic potential when used in combination with other anticancer drugs. Here, we address different pathways which are activated by furanocoumarins and their therapeutic efficacy in various tumors. Ideally, this review will trigger interest in furanocoumarins and their potential efficacy and safety as cancer-lessening agents.
Article DOI & Crossmark Data
DOI : https://doi.org/10.3390/ijms21165622
Article Subject Details
Article Keywords Details
Article File
Full Text PDFArticle References
- (1). 10.3389/fpls.2016.01667
- (2). 10.1155/2020/8602879
- (3). 10.2174/1573394712666160617081638
- (4). 10.1080/14786419.2014.999336
- (5). 10.1016/j.biotechadv.2019.04.007
- (6). 10.1016/j.nurpra.2017.12.007
- (7). 10.1016/j.drudis.2015.01.009
- (8). 10.1016/j.phrs.2020.104689
- (9). 10.1016/B978-0-444-63430-6.00005-9
- (10). 10.1016/j.fct.2018.01.030
- (11). 10.1016/j.fitote.2020.104492
- (12). 10.1016/j.bioorg.2014.07.008
- (13). 10.1016/j.biopha.2018.06.053
- (14). 10.1021/acsmedchemlett.8b00170
- (15). 10.1039/C8RA09755K
- (16). 10.3390/ijms19030746
- (17). 10.3892/mmr.2017.7219
- (18). 10.1016/j.bmcl.2018.12.048
- (19). 10.1016/j.ejmech.2019.07.025
- (20). 10.1248/cpb.47.96
- (21). 10.1055/s-2006-962801
- (22). 10.1515/chem-2017-0001
- (23). 10.3389/fonc.2013.00120
- (24). 10.1182/blood-2002-07-2130
- (25). 10.1158/1940-6207.CAPR-10-0251
- (26). 10.3892/ol.2017.7641
- (27). 10.1093/ecam/nen087
- (28). 10.1161/01.ATV.0000015078.09208.92
- (29). 10.1016/j.suronc.2012.06.001
- (30). 10.1016/j.clon.2006.11.013
- (31). 10.1242/jcs.01483
- (32). 10.3892/or.2016.5166
- (33). 10.3390/molecules23071601
- (34). 10.3390/ijms19124048
- (35). 10.1002/mnfr.200900283
- (36). 10.1248/bpb.b15-00957
- (37). 10.1091/mbc.11.12.4347
- (38). 10.4161/cbt.20082
- (39). 10.4255/mcpharmacol.09.05
- (40). 10.1080/10408398.2019.1661827
- (41). 10.1101/cshperspect.a001651
- (42). 10.1016/j.phymed.2019.152883
- (43). 10.1016/S0024-3205(02)02173-2
- (44). 10.1016/j.biopha.2019.109401
- (45). 10.3892/mmr.2017.7706
- (46). 10.1016/j.bbrc.2018.01.071
- (47). 10.3389/fcimb.2018.00178
- (48). 10.1016/S1368-7646(02)00120-6
- (49). 10.1016/S0898-6568(01)00271-6
- (50). 10.1016/j.jep.2017.06.010
- (51). 10.3892/or.2016.4586
- (52). 10.1016/j.biopha.2018.08.145
- (53). 10.1016/j.yexcr.2007.06.018
- (54). 10.1080/01926230701320337
- (55). 10.4314/tjpr.v14i8.12
- (56). 10.3892/or.2016.4833
- (57). 10.1007/s11010-012-1372-1
- (58). 10.1002/ddr.21414
- (59). 10.5114/aoms.2019.86226
- (60). 10.1007/s10549-012-2282-3
- (61). 10.1002/tox.22685
- (62). 10.3329/bjp.v11i2.24644
- (63). 10.1159/000430360
- (64). 10.1034/j.1600-0773.2002.910107.x
- (65). 10.2174/1871520614666140922122358
- (66). 10.1159/000331641
- (67). 10.3892/ol.2016.5387
- (68). 10.3892/or.2017.6147
- (69). 10.1002/ptr.2043
- (70). 10.1055/s-0032-1328130
- (71). 10.1186/s40659-019-0241-8
- (72). 10.1186/1475-2867-14-16
- (73). 10.2174/1568026618666180523104541
- (74). 10.1016/j.dnarep.2016.04.008
- (75). 10.1038/sj.onc.1208615
- (76). 10.3892/mmr.2019.9810
- (77). 10.2174/1871520619666191010102526
- (78). 10.1007/s11418-012-0719-y
- (79). 10.5306/wjco.v5.i3.348
- (80). 10.2174/156800909788486786
- (81). 10.1186/s13046-016-0468-y
- (82). 10.18632/oncotarget.25267
- (83). 10.4155/fmc.13.17
- (84). 10.1016/j.jep.2017.03.033
- (85). 10.3390/cells8111380
- (86). 10.1200/JCO.2016.69.0032
- (87). 10.1158/0008-5472.CAN-17-2066
- (88). 10.3892/etm.2019.7985
- (89). 10.1016/S0887-2333(03)00014-6
- (90). 10.1038/s41598-018-32438-7
- (91). 10.4161/cbt.11.2.14622
- (92). 10.3390/ijms19113466
- (93). 10.1038/nrm3330
- (94). 10.1186/s12943-015-0403-4
- (95). 10.3892/ijo.2014.2297
- (96). 10.1038/s41598-019-55309-1
- (97). 10.1016/j.jfda.2016.11.008
- (98). 10.3390/molecules24040722
- (99). 10.1016/j.jash.2014.04.006
- (100). 10.1080/13880200701741088
- (101). 10.6026/97320630004233
- (102). 10.1016/j.fitote.2015.03.025
- (103). 10.3390/molecules22060871
- (104). 10.3892/mmr.2016.5098
- (105). 10.1155/2017/5647281
- (106). 10.1038/nrc2789
- (107). 10.5732/cjc.011.10320
- (108). 10.1016/j.taap.2017.10.018
- (109). 10.1158/0008-5472.CAN-06-4582
- (110). 10.1038/s41598-019-52162-0
- (111). 10.1016/j.phymed.2014.03.008
- (112). 10.3109/13880209.2016.1141221
- (113). 10.1155/2020/3028387
- (114). 10.1111/bph.14816
- (115). 10.1038/sj.bjp.0703433
- (116). 10.1021/tx025636d
- (117). 10.1007/978-0-387-74039-3_10
- (118). 10.5603/FHC.2012.0052
- (119). 10.1007/s13277-015-3591-z
- (120). 10.1016/j.tiv.2006.09.016
- (121). 10.1016/j.febslet.2010.04.001
- (122). 10.1007/s11418-013-0774-z
- (123). 10.1016/j.jaad.2011.04.004
- (124). 10.1200/JCO.2015.63.8643
- (125). 10.5772/65712
- (126). 10.1371/journal.pone.0162078
- (127). 10.1016/j.fct.2018.10.027
- (128). 10.1016/j.addr.2012.09.006
- (129). 10.4155/tde-2018-0062
- (130). 10.1080/10717544.2018.1464084
- (131). 10.1080/13880209.2018.1548625
More Article by Dr. Salman Ahmed
The seeds of cleome viscosa are used in traditional systems of medicine for the treatment of many diseases in asia. this study evaluated fixed oil from the seeds of cleome viscosa...
Plants have been used as medicine for the treatment of diseases for thousands of years. these herbal remedies, although natural, can cause some serious damaging effects on the vita...
The current study was conducted to explore the antiemetic activity of ten aromatic medicinal plants viz., carissa carandus l. (fruits), chichorium intybus l (flowers), cinnamum tam...
Crude methanol extracts of the leaves of adenanthera pavonina l., peltoforum roxburghii l, prosopis cineraria l., and prosopis juliflora dc., were evaluated for anti-emetic activit...
More Clinical pharmacology Articles
Metapuf: a challenge response pair generator
Views: 1.3K
Thrombolytic therapy versus primary percutaneous coronary intervention: role of clinical pharmacist
Views: 1.1K